Concepedia

Abstract

No AccessJournal of UrologyUrological Survey: Abstracts: Urinary Tract Infection1 Apr 1998Valaciclovir for the Suppression of Recurrent Genital HSV Infection: A Placebo Controlled Study of Once Daily Therapy R. Patel, N.J. Bodsworth, P. Woolley, B. Peters, G. Vejlsgaard, S. Saari, A. Gibb, and J. Robinson R. PatelR. Patel More articles by this author , N.J. BodsworthN.J. Bodsworth More articles by this author , P. WoolleyP. Woolley More articles by this author , B. PetersB. Peters More articles by this author , G. VejlsgaardG. Vejlsgaard More articles by this author , S. SaariS. Saari More articles by this author , A. GibbA. Gibb More articles by this author , and J. RobinsonJ. Robinson More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)63674-7AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Valaciclovir for the Suppression of Recurrent Genital HSV Infection: A Placebo Controlled Study of Once Daily Therapy." The Journal of Urology, 159(4), p. 1421 The International Valaciclovir HSV Study Group; Royal South Hants Hospital, Southampton, Withington Hospital, Manchester, Royal Free Hospital, London and Glaxo Wellcome Research and Development, Bechenham, United Kingdom, Rigshospitalet, Copenhagen, Denmark, Laakariasema Pulssi, Turku, Finland and Taylor Square Private Clinic, Sydney, Australia.© 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 159Issue 4April 1998Page: 1421 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information R. Patel More articles by this author N.J. Bodsworth More articles by this author P. Woolley More articles by this author B. Peters More articles by this author G. Vejlsgaard More articles by this author S. Saari More articles by this author A. Gibb More articles by this author J. Robinson More articles by this author Expand All Advertisement PDF downloadLoading ...